Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gossamer Bio Inc 3115 Merryfield Row Suite 120 SAN DIEGO CA 92121 USA

www.gossamerbio.com Employees: 145 P: 858-684-1300

Sector:

Medical

Description:

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 833,242
Enterprise Value, $K 787,172
Shares Outstanding, K 231,456
Annual Sales, $ 114,700 K
Annual Net Income, $ -56,530 K
Last Quarter Sales, $ 13,290 K
Last Quarter Net Income, $ -48,220 K
EBIT, $ -160,820 K
EBITDA, $ -168,650 K
60-Month Beta 1.92
% of Insider Shareholders 6.70%
% of Institutional Shareholders 81.23%
Float, K 215,948
% Float 93.30%
Short Volume Ratio 0.35

Growth:

1-Year Return 297.85%
3-Year Return 31.87%
5-Year Return -68.39%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 11/05/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.69
EPS Growth vs. Prev Qtr -23.53%
EPS Growth vs. Prev Year -50.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

GOSS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,774.72%
Return-on-Assets % -59.74%
Profit Margin % -49.29%
Debt/Equity 0.00
Price/Sales 7.30
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.36
Interest Coverage -3.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar